Basal cell carcinoma and squamous cell carcinoma are the two most common types of non-melanoma skin cancer. These cancers begin in different layers of the skin. Squamous cell carcinoma starts in ...

Squamous cell carcinoma of the throat is a type of head and neck cancer that develops in the cells that line the throat. It may develop in the windpipe, tonsils, or voice box. Squamous cell ...

Cutaneous squamous-cell carcinoma accounts for 20% of all cutaneous cancers. 1 The incidence over the past several decades has been increasing worldwide among White populations, an increase that ...

A patient shares his experience with a squamous cell carcinoma diagnosis, treatment and recovery. It was a Friday afternoon, and I was sitting in slow-moving traffic on FM 1960 in Houston, on my way ...

A similar type of skin cancer is squamous cell carcinoma, and they're often lumped together in statistics, said Dr. William Dahut, the American Cancer Society's chief scientific officer.

It is probably a squamous cell carcinoma. Please see a dermatologist and have it biopsied.' Dr Brown also urged the public to take preventative steps to avoid the disease. ‘You can prevent ...

Squamous cell carcinoma of the lip often develops from a precancerous lesion called actinic cheilitis. Both conditions can cause changes in the color and texture of your lip. Your outlook is best ...

Checkpoint Therapeutics, Inc. announced that the FDA has approved UNLOXCYT™ (cosibelimab-ipdl) for treating adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced ...

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the ...

consistent with keratinizing squamous cell carcinoma (SCC; Figure 1A). A suspicion of metastatic SCC was raised. However, chest X-ray, laryngologic consultation, esophagogastroduodenoscopy, and ...

The FDA has approved cosibelimab-ipdl for the treatment of adults with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or radiation.